Combined silencing expression of MGMT with EGFR or galectin-1 enhances the sensitivity of glioblastoma to temozolomide

Khaled Messaoudi, Anne Clavreul, Fabienne Danhier, Patrick Saulnier, Jean-Pierre Benoit, Frederic Lagarce
  • European Journal of Nanomedicine, January 2015, De Gruyter
  • DOI: 10.1515/ejnm-2014-0041

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: frederic Lagarce

In partnership with: